FTC Spoke, Kaleo and Impax Listened: Orange Book Patent Delistings Begin
December 14, 2023, 1:06 PM
By: Ross E. Blau
As discussed last month, the FTC sent letters to 10 pharmaceutical companies, asserting that their listing of over 100 patents in FDA’s Orange Book for a variety of products was improper. Shortly thereafter, the FTC began using the administrative process with FDA to challenge these patent listings, and all of the companies had until December 16, 2023 to respond.
It appears that prior to this deadline at least two companies – Impax Labs and Kaleo, Inc. – may have felt pressure to reconsider their patent listings.
Specifically, Impax delisted both of its patents directed to Adrenaclick, the same patents that the FTC had noticed in its November 7, 2023 letter. There are currently no approved generic applicants for Adrenaclick, and no additional patents directed to Adrenaclick in the Orange Book. Similarly, Kaleo delisted eight patents directed to AUVI-Q, the same patents that the FTC had noticed in its letter to Kaleo. Given that the Orange Book lists more than twenty patents for AUVI-Q, it seems that any potential generic applicant still has quite the battle ahead.
It will be interesting to continue to monitor for any further patent delistings, particularly with the December 16, 2023 deadline coming up. Time will tell whether the FTC will take any further action against those companies that don’t follow Kaleo and Impax’s paths. And, it remains to be seen whether we can expect further fallout in private litigation from FTC’s recent, more aggressive actions in this area.

To subscribe to our publications, click here.
Tags
News & Insights
News & Insights
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust
HNBA/VIA Annual Convention 2025
Sponsorship
Antitrust
Key Appellate Decisions Shaping Antitrust Strategy
Webinar
Antitrust
ACI 12th Annual Summit for Women Leaders in Life Sciences Law
Speaking Engagement
Intellectual Property
National LGBTQ+ Bar Association Lavender Law Conference and Career Fair 2025
Sponsorship
National Bar Association 100th Annual Convention and Exhibits
Sponsorship
Antitrust
Axinn Serves as Global Coordinating Counsel for Worldpay in its $24.5 Billion Acquisition by Global Payments
Deals & Cases
Antitrust
Axinn Attorneys Named to the 2025 Lawdragon 500 X – The Next Generation Guide
Awards & Recognitions
Keeping Pace: Updates in Cartel Enforcement
Webinar
Antitrust